D-0594-2018 Class II Terminated
FDA drug recall D-0594-2018 was initiated by Hetero Labs, Ltd. - Unit III on Jan 10, 2018 and is designated Class II. Reason for recall: CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications. The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 3000 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 14, 2018
- Initiation Date
- Jan 10, 2018
- Termination Date
- Sep 21, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3000 bottles
Product description
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30
Reason for recall
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Distribution pattern
NJ Only
Code information
Lot #: ARI17089, ARI17090, Exp. 5/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0594-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026